Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A.

EMBO J. 1987 Nov;6(11):3341-51.

3.

Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways.

Kinashi T, Escobedo JA, Williams LT, Takatsu K, Springer TA.

Blood. 1995 Sep 15;86(6):2086-90.

4.

Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.

Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, et al.

Blood. 1995 Feb 1;85(3):790-8.

5.

Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.

Ratajczak MZ, Kuczynski WI, Sokol DL, Moore JS, Pletcher CH Jr, Gewirtz AM.

Blood. 1995 Sep 15;86(6):2161-7.

6.

The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells.

Tauchi T, Feng GS, Marshall MS, Shen R, Mantel C, Pawson T, Broxmeyer HE.

J Biol Chem. 1994 Oct 7;269(40):25206-11.

7.

Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.

Albor A, Thraves PJ, Dritschilo A, Notario V.

Oncogene. 1996 Oct 17;13(8):1755-63.

PMID:
8895522
8.

Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group.

Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC.

Blood. 1994 Nov 15;84(10):3465-72.

9.

Structure-function analyses of the kit receptor for the steel factor.

Blechman JM, Lev S, Givol D, Yarden Y.

Stem Cells. 1993 Jul;11 Suppl 2:12-21. Review.

PMID:
7691317
10.
11.

Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.

Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI.

Proc Natl Acad Sci U S A. 1988 Aug;85(15):5389-93.

13.

Steel factor and c-kit protooncogene: genetic lessons in signal transduction.

Lev S, Blechman JM, Givol D, Yarden Y.

Crit Rev Oncog. 1994;5(2-3):141-68. Review.

PMID:
7531500
14.

The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice.

Duttlinger R, Manova K, Berrozpe G, Chu TY, DeLeon V, Timokhina I, Chaganti RS, Zelenetz AD, Bachvarova RF, Besmer P.

Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3754-8.

15.

The human met oncogene is a member of the tyrosine kinase family.

Gonzatti-Haces M, Park M, Dean M, Blair DG, Vande Woude GF.

Princess Takamatsu Symp. 1986;17:221-32. Review.

PMID:
3332011
16.

Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C.

Blume-Jensen P, Rönnstrand L, Gout I, Waterfield MD, Heldin CH.

J Biol Chem. 1994 Aug 26;269(34):21793-802.

17.

Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.

Kozma SC, Redmond SM, Fu XC, Saurer SM, Groner B, Hynes NE.

EMBO J. 1988 Jan;7(1):147-54.

19.
20.

Structural and functional aspects of the receptors for platelet-derived growth factor.

Westermark B, Claesson-Welsh L, Heldin CH.

Prog Growth Factor Res. 1989;1(4):253-66. Review.

PMID:
2562360

Supplemental Content

Support Center